| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae1ceb9a3655ff18e2f217d8ee8fc3a0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0667
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 |
| filingDate |
2016-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f609d53d41ebfd3b5d524b2fbeed91b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36ca128563702f701e779c4c2a871319
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_900a3869df5c7c5af2d1452fae4a4a20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6fe089da65654b83cc32e87ba2748f5 |
| publicationDate |
2018-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180043834-A |
| titleOfInvention |
Cell growth methods and therapeutic compositions |
| abstract |
The present invention relates to methods for the production of mesenchymal stem cells (MSCs), in particular methods for methods for large scale production of MSCs such as homologous MSCs for use in the treatment of various diseases in humans and other animals . The present invention also relates to methods that enable the selection of suitable donor cells suitable for large scale production of MSCs. The present invention also relates to refined MSCs produced by the methods of the present invention. The invention also relates to the use of platelet lysates and to the production of extracellular matrix-enriched secretions in methods for producing cultures of MSCs. The present invention also relates to methods for the preparation of compositions comprising one or more component (s) secreted from cultured MSCs with improved stability characteristics. The present invention also relates to methods for treating inflammatory conditions, including pain relief, by administering a high molecular weight sugar conjugate-enriched condition medium, and methods for treating neurogenic pain by administering a high molecular weight sugar conjugate- Lt; / RTI > |
| priorityDate |
2015-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |